Federal Register Notice: FDA determines that Brethine (terbutaline sulfate) injection was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve ANDAs for terbutaline sulfate injection if all other legal and regulatory requirements are met. To view this notice, click here.
